For help on how to get the results you want, see our search tips.
2 results
Medicine type
Additional monitoring Remove Additional monitoring filter
Exceptional circumstances Remove Exceptional circumstances filter
Biosimilar Remove Biosimilar filter
-
List item
Referral: Rubraca (updated)
rucaparib, associated names: Rubraca, Article 20 procedures
Status: Procedure started, Last updated: 06/05/2022 -
List item
Referral: Janus Kinase inhibitors (JAKi)
tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Procedure started, Last updated: 11/02/2022